aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.-Reference-Cited by-同舟云学术

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Published:2013-05-20 Issue:15_suppl Volume:31 Page:5-5
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gray Richard G.¹,Rea Daniel²,Handley Kelly²,Bowden Sarah Jane²,Perry Philip³,Earl Helena Margaret⁴,Poole Christopher John⁵,Bates Tom⁶,Chetiyawardana Shan⁷,Dewar John A.⁸,Fernando Indrajit Nalinika⁷,Grieve Robert⁹,Nicoll Jonathan¹⁰,Rayter Zenor¹¹,Robinson Anne¹²,Salman Asad¹³,Yarnold John¹⁴,Bathers Sarah²,Marshall Andrea¹⁵,Lee Martin¹⁶,

Affiliation:

1. University of Oxford, Oxford, United Kingdom

2. University of Birmingham, Birmingham, United Kingdom

3. AO Foundation, Zurich, Switzerland

4. NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom

5. Department of Medical Oncology, Arden Cancer Centre, University Hospital Coventry and Warwickshire and University of Warwick, Coventry, United Kingdom

6. William Harvey Hospital, Ashford, United Kingdom

7. University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom

8. University of Dundee, Dundee, United Kingdom

9. University Hospital, Coventry, United Kingdom

10. North Cumbria University Hospitals, Carlisle, United Kingdom

11. University of Bristol NHS Foundation Trust, Bristol, United Kingdom

12. Southend University Hospital, Southend, United Kingdom

13. Worthing Hospital, Worthing, United Kingdom

14. The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

15. Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom

16. Arden NHS, Coventry, United Kingdom

Abstract

5 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Sunday, June, 2, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dedicated menopausal after cancer clinic may improve adherence to endocrine therapy for breast cancer: A population based study;Clinical Breast Cancer;2024-09

2. Systemic Therapy for Breast Cancer;Breast Cancer;2024

3. Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer;BMC Cancer;2023-06-30

4. SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022);Clinical and Translational Oncology;2023-06-16

5. A Review on Current and Novel Treatment Regimen on Luminal A Breast Cancer;Asian Journal of Pharmacy and Technology;2023-05-30